Undetermined risk factors and modes of transmission for Candida auris infection — Colombia, 2016
Appendix 2.Interview Questions for Healthcare Providers
Did you observe anything notable about patients infected with C. auris or C. haemulonii* compared with those infected with other Candida species?
In terms of demographic and clinical characteristics?
In terms of possible prehospital exposures, including transfer from other hospitals?
In terms of patient outcomes?
Did you observe any possible evidence of transmission of C. auris or C. haemulonii between patients on a unit or within the hospital? If so, what?
Did you observe recurrent C. auris or C. haemulonii infections within a patient?
Do you have any reason to believe that a patient was persistently colonized with C. auris or C. haemulonii?
What type of daily and terminal cleaning methods are used at your hospital, and what cleaning agents are used?
Are there special precautions (e.g., Contact Precautions) used for patients with certain infections or colonization at your hospital? If so, what?
Do you have any hypotheses or guesses about the source of C. auris or C. haemulonii infections and why they have recently emerged at your hospital?
Do you have any suggestions for this investigation in to C. auris or C. haemulonii infections?
Is there anything else we should know?
*Note that C. haemulonii is included in the questions because most C. auris cases in Colombia were initially misidentified as C. haemulonii
| File Type | application/msword |
| Author | Armstrong, Paige Alexandria (CDC) |
| Last Modified By | Bosch, Stacey A. (CDC/OPHSS/CSELS) |
| File Modified | 2016-09-16 |
| File Created | 2016-09-16 |